Targeting NFkappaB protects tendons from injury

Of the 32 million musculoskeletal injuries per year documented in the US alone, 45% are injuries to tendons, ligaments,...

Polyneuron Pharma raise CHF22.5m in Series A financing

Polyneuron Pharmaceuticals AG develops glycopolymers that mimick epitopes of autoantibodies attacking the nervous system, providing a new...

Philogen SpA raises €62m to push registration

The VC-independent company founded by Dario Neri (ETH Zürich) in 1996 develops proprietary and partnered immunocytokines, that is antibody-cytokine...

Mobidiag secures €25m loan from EIB

Molecular diagnostics that can more rapidly identify microbial pathogens and antibiotic resistance than culture-based methods are a pillar of the...

AMR network CARB-X expands reach

Launched in the US by BARDA in 2016, CARB-X has a budget of US$450m from 2017 till 2021 for antibacterial R&D, particularly for investments...

Genfit prices IPO at $135m

As reported in early March, Genfit's offering consists of a Nasdaq IPO of American Depositary Shares (ADS) and an ex-US private placement of ordinary...

Researchers report how body fat affects imune cells

While the initial discovery of the presence of immune cells in fat was a surprising revelation to the field of immunology, it is now well-known that...